831
Participants
Start Date
May 31, 2007
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
Ilaprazole
Ilaprazole 5 mg, capsules, orally, once daily for up to 8 weeks.
Ilaprazole
Ilaprazole 20 mg, capsules, orally, once daily for up to 8 weeks.
Ilaprazole
Ilaprazole 40 mg, capsules, orally, once daily for up to 8 weeks.
Lansoprazole
Lansoprazole 30 mg, capsules, orally, once daily for up to 8 weeks.
Hueytown
Huntsville
Chandler
Phoenix
Tempe
Tucson
Sherwood
Anaheim
Cypress
Encinitas
Garden Grove
Irvine
Lancaster
Mission Hills
Oakland
Orange
Pasadena
San Diego
West Covina
Colorado Springs
Longmont
Pueblo
Bristol
Washington D.C.
Longwood
Miami
New Smyrna Beach
Pembroke Pines
Tampa
Zephyrhills
Atlanta
Conyers
Newnan
Tucker
Boise
Moline
Rockford
Clive
Davenport
Dubuque
Wichita
Metairie
Chevy Chase
Prince Frederick
Olive Branch
Jefferson City
Kansas City
Mexico
Egg Harbor
Albuquerque
Binghamton
Great Neck
Rochester
Chapel Hill
Fayetteville
Greensboro
Raleigh
Wilmington
Winston-Salem
Cincinnati
Dayton
Norman
Oklahoma City
Medford
Portland
Beaver Falls
Harrisburg
Lansdale
Warwick
Anderson
Charleston
Goose Creek
Mt. Pleasant
Sioux Falls
Bristol
Chattanooga
Johnson City
Nashville
Amarillo
Austin
Beaumont
Bryan
El Paso
Fort Worth
Houston
Odessa
San Antonio
Midvale
Ogden
Newport News
Norfolk
Spokane
Milwaukee
Monroe
Lead Sponsor
Takeda
INDUSTRY